167 related articles for article (PubMed ID: 31103160)
1. The acceleration of melanoma in situ: A population-based study of melanoma incidence trends from Victoria, Australia, 1985-2015.
Curchin DJ; Forward E; Dickison P; Harris VR; McCormack CJ; Smith SD
J Am Acad Dermatol; 2019 Jun; 80(6):1791-1793. PubMed ID: 31103160
[No Abstract] [Full Text] [Related]
2. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
3. Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.
Wei EX; Qureshi AA; Han J; Li TY; Cho E; Lin JY; Li WQ
J Am Acad Dermatol; 2016 Oct; 75(4):698-705. PubMed ID: 27436155
[TBL] [Abstract][Full Text] [Related]
4. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
5. Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
Higgins HW; Lee KC; Galan A; Leffell DJ
J Am Acad Dermatol; 2015 Aug; 73(2):181-90, quiz 191-2. PubMed ID: 26183967
[TBL] [Abstract][Full Text] [Related]
6. The age-specific effect modification of male sex for ulcerated cutaneous melanoma.
Richardson BS; Anderson WF; Barnholtz-Sloan JS; Tucker MA; Gerstenblith MR
JAMA Dermatol; 2014 May; 150(5):522-5. PubMed ID: 24599332
[TBL] [Abstract][Full Text] [Related]
7. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of left-sided skin cancers.
Butler ST; Fosko SW
J Am Acad Dermatol; 2010 Dec; 63(6):1006-10. PubMed ID: 20226568
[TBL] [Abstract][Full Text] [Related]
9. Changing trends in the incidence of invasive melanoma in Victoria, 1985-2015.
Curchin DJ; Harris VR; McCormack CJ; Smith SD
Med J Aust; 2018 Apr; 208(6):265-269. PubMed ID: 29614940
[No Abstract] [Full Text] [Related]
10. Malignant melanoma: it pays to be a woman.
Mashiah J; Brenner S
Skinmed; 2003; 2(3):183-7. PubMed ID: 14673297
[No Abstract] [Full Text] [Related]
11. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
Beaudoux O; Riffaud L; Barbe C; Grange F
Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
[TBL] [Abstract][Full Text] [Related]
12. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031.
Whiteman DC; Green AC; Olsen CM
J Invest Dermatol; 2016 Jun; 136(6):1161-1171. PubMed ID: 26902923
[TBL] [Abstract][Full Text] [Related]
13. The burden of malignant melanoma--lessons to be learned from Austria.
Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
[TBL] [Abstract][Full Text] [Related]
14. Melanoma in xeroderma pigmentosum type C children: Overrepresentation of desmoplastic type?
Leclerc-Mercier S; Bodemer C; Michel B; Soufir N; Bourdon-Lanoy E; Frassatti-Biaggi A; Delanoe P; Fraitag S; Hadj-Rabia S
J Am Acad Dermatol; 2015 Jun; 72(6):e173-6. PubMed ID: 25981029
[No Abstract] [Full Text] [Related]
15. The systematic relationship between melanomas diagnosed in situ and when invasive.
Lee JA
Melanoma Res; 2001 Oct; 11(5):523-9. PubMed ID: 11595891
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting Breslow thickness: Results from a survey of 114 Western Australian patients with thicker melanoma.
Hille DM; Mahoney SD; Quirk CJ
Australas J Dermatol; 2019 Nov; 60(4):342-343. PubMed ID: 31169320
[No Abstract] [Full Text] [Related]
17. Trends in incidence of thick, thin and in situ melanoma in Europe.
Sacchetto L; Zanetti R; Comber H; Bouchardy C; Brewster DH; Broganelli P; Chirlaque MD; Coza D; Galceran J; Gavin A; Hackl M; Katalinic A; Larønningen S; Louwman MWJ; Morgan E; Robsahm TE; Sanchez MJ; Tryggvadóttir L; Tumino R; Van Eycken E; Vernon S; Zadnik V; Rosso S
Eur J Cancer; 2018 Mar; 92():108-118. PubMed ID: 29395684
[TBL] [Abstract][Full Text] [Related]
18. Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study.
Veierød MB; Page CM; Aaserud S; Bassarova A; Jacobsen KD; Helsing P; Robsahm TE
J Am Acad Dermatol; 2018 Jul; 79(1):118-125.e1. PubMed ID: 29580861
[TBL] [Abstract][Full Text] [Related]
19. Characterizing subsequent primary melanomas (SPM) in adolescents and young adults: A population-based study from 1973 to 2011.
Fu T; Swetter SM; Tao L; Geller AC; Clarke CA; Keegan TH
J Am Acad Dermatol; 2016 Jan; 74(1):181-182.e3. PubMed ID: 26702802
[No Abstract] [Full Text] [Related]
20. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
